2026/2027 NR 546 Final PRACTICE EXAM Psychopharmacology with questions and answers (graded A+)
2026/2027 NR 546 Final PRACTICE EXAM Psychopharmacology with questions and answers (graded A+) 1. MAOIs (monoamine oxidase inhibitors) affect which neurotransmitters? A. Serotonin, Dopamine, Norepinephrine B. Serotonin, GABA, Glutamate C. Acetylcholine, Dopamine, Norepinephrine D. Dopamine, GABA, Acetylcholine 2. Which of the following is considered first line treatment for depression? A. SSRI B. FGA C. SNRI D. MAOI A. Serotonin, Dopamine, Norepinephrine A. SSRI 3. When treating a patient for major depression disorder C. Escitalopram which medication would the PMHNP consider first? A. Depakote B. Selegiline C. Escitalopram D. Isocarboxazid
Document information
- Uploaded on
- March 30, 2026
- Number of pages
- 25
- Written in
- 2025/2026
- Type
- Exam (elaborations)
- Contains
- Questions & answers